1. Home
  2. NUVB vs HTB Comparison

NUVB vs HTB Comparison

Compare NUVB & HTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUVB
  • HTB
  • Stock Information
  • Founded
  • NUVB 2018
  • HTB 1926
  • Country
  • NUVB United States
  • HTB United States
  • Employees
  • NUVB N/A
  • HTB N/A
  • Industry
  • NUVB Biotechnology: Pharmaceutical Preparations
  • HTB
  • Sector
  • NUVB Health Care
  • HTB
  • Exchange
  • NUVB Nasdaq
  • HTB NYSE
  • Market Cap
  • NUVB 679.9M
  • HTB 636.8M
  • IPO Year
  • NUVB N/A
  • HTB N/A
  • Fundamental
  • Price
  • NUVB $2.09
  • HTB $39.07
  • Analyst Decision
  • NUVB Strong Buy
  • HTB Buy
  • Analyst Count
  • NUVB 6
  • HTB 1
  • Target Price
  • NUVB $7.83
  • HTB $43.00
  • AVG Volume (30 Days)
  • NUVB 8.9M
  • HTB 54.5K
  • Earning Date
  • NUVB 08-04-2025
  • HTB 07-23-2025
  • Dividend Yield
  • NUVB N/A
  • HTB 1.25%
  • EPS Growth
  • NUVB N/A
  • HTB N/A
  • EPS
  • NUVB N/A
  • HTB 3.16
  • Revenue
  • NUVB $10,957,000.00
  • HTB $193,954,000.00
  • Revenue This Year
  • NUVB $101.21
  • HTB $6.54
  • Revenue Next Year
  • NUVB $410.28
  • HTB $1.75
  • P/E Ratio
  • NUVB N/A
  • HTB $12.36
  • Revenue Growth
  • NUVB N/A
  • HTB 0.68
  • 52 Week Low
  • NUVB $1.54
  • HTB $28.53
  • 52 Week High
  • NUVB $3.97
  • HTB $38.99
  • Technical
  • Relative Strength Index (RSI)
  • NUVB 51.54
  • HTB N/A
  • Support Level
  • NUVB $1.87
  • HTB N/A
  • Resistance Level
  • NUVB $2.10
  • HTB N/A
  • Average True Range (ATR)
  • NUVB 0.16
  • HTB 0.00
  • MACD
  • NUVB 0.01
  • HTB 0.00
  • Stochastic Oscillator
  • NUVB 91.23
  • HTB 0.00

About NUVB Nuvation Bio Inc.

Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).

About HTB HOMETRUST BANCSHARES INC

HomeTrust Bancshares Inc operates as a bank holding company. It engaged in the business of planning, directing and coordinating the business activities of the Bank. The Bank is a North Carolina state chartered bank and provides a range of retail and commercial banking products. Company's principal business consists of attracting deposits from the general public and investing those funds, along with borrowed funds, in commercial real estate loans, construction and development loans, commercial and industrial loans, equipment finance leases, municipal leases, loans secured by first and second mortgages on one-to-four family residences including home equity loans and other consumer loans.

Share on Social Networks: